Comparison of VWF testing in 113 ZPMCB-VWD healthy control subjects
| . | Mean . | Range (± 2 SD) . |
|---|---|---|
| VWF:Ag, IU/dL | 109 | 53-225 |
| VWF:RCo, IU/dL | 95 | 48-191 |
| VWF:IbCo ELISA, U/dL | 102 | 46-227 |
| FVIII:C, IU/dL | 106 | 58-191 |
| VWF:CB, U/dL | 130 | 60-282 |
| VWFpp, U/dL | 91 | 53-156 |
| . | Mean . | Range (± 2 SD) . |
|---|---|---|
| VWF:Ag, IU/dL | 109 | 53-225 |
| VWF:RCo, IU/dL | 95 | 48-191 |
| VWF:IbCo ELISA, U/dL | 102 | 46-227 |
| FVIII:C, IU/dL | 106 | 58-191 |
| VWF:CB, U/dL | 130 | 60-282 |
| VWFpp, U/dL | 91 | 53-156 |
Means and SDs are calculated from log-transformed data to achieve a normal distribution. All assays used a normal control calibrated against either the 5th World Health Organization standard plasma or the 3rd International Society of Thrombosis and Haemostasis standard plasma.